Bioxcel Therapeutics, Inc. · NASDAQ:BTAI

Integrated Core Strategies (US) LLC reported a 8.40% stake in Bioxcel Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 9, 2026

Integrated Core Strategies (US) LLC reported a 8.40% stake in Bioxcel Therapeutics, Inc., 1,833,717 shares, as a passive investor on Dec 31, 2025. Filed Feb 9, 2026 (Schedule 13G/A).

Stake
8.40%
Shares
1,833,717
Intent
Passive
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Integrated Core Strategies (US) LLC8.40%1,833,717
Millennium Management LLC8.40%1,835,192
Millennium Group Management LLC8.40%1,835,192
Israel A. Englander8.40%1,835,192

Source

View original at SEC

Related